Renew and expand the National Strategy for Drugs for Rare Diseases
Jul 21, 2026 / News
As Premiers gather for the Council of the Federation meeting, CORD is calling on First Ministers to renew and strengthen Canada’s National Strategy for Drugs for Rare Diseases before current agreements expire in 2027.
The strategy is working: patients are gaining faster access to treatments, and Canada is building the diagnosis, genomics, data and care capacity needed for the future.
Now is the time to secure Phase 2 — and keep momentum going.
Read the full letter.
Read More
Rare Disease Readiness Survey
Jul 14, 2026 / News
CORD is inviting members of the rare disease community in Canada, including patients, caregivers, clinicians, researchers, patient organizations, policy partners, and health-system leaders, to participate in the Rare Disease Readiness Survey.
Read More
What was your “moment that mattered”?
Jun 23, 2026 / News
We're inviting patients, caregivers, family members, and advocates to share one key moment from their experience.
Share your story and help improve diagnosis, care, and support for others.
Read More
The Canadian Organization for Rare Disorders Hereby Gives Notice of its Annual General Meeting
Jun 5, 2026 / News
The Canadian Organization for Rare Disorders hereby gives notice of its Annual General Meeting, to be held on August 18, 2026, at 3:00 p.m. ET (updated meeting time).
Read More
Strengthening Canada’s Innovative Medicines Strategy
Jun 2, 2026 / News
Strengthening Canada’s Innovative Medicines Strategy: From Receptivity to Implementation. Follow-up reflections for the Pharmaceutical and Life Sciences Sector Task Force
Read More
